Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Inspira Technologies Oxy BHN ( (IINN) ) has provided an update.
On July 1, 2025, Inspira Technologies Oxy B.H.N. Ltd. announced an increase in the maximum aggregate offering price of its ordinary shares under a Sales Agreement with A.G.P./Alliance Global Partners, raising it from $1,917,052 to $7,117,720. This move is expected to enhance the company’s financial flexibility and strengthen its market position by potentially increasing its capital resources, which could be utilized for further development and expansion efforts.
The most recent analyst rating on (IINN) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.
Spark’s Take on IINN Stock
According to Spark, TipRanks’ AI Analyst, IINN is a Underperform.
The overall stock score reflects significant financial instability, as indicated by ongoing losses and reliance on external funding. The technical analysis shows bearish sentiment, with the stock under pressure. Valuation is challenging due to negative earnings and lack of dividend yield, making the stock less appealing to investors.
To see Spark’s full report on IINN stock, click here.
More about Inspira Technologies Oxy BHN
Inspira Technologies Oxy B.H.N. Ltd. operates in the medical technology industry, focusing on developing respiratory support technologies. The company is based in Ra’anana, Israel, and is known for its innovative solutions aimed at improving patient care in respiratory medicine.
Average Trading Volume: 516,320
Technical Sentiment Signal: Hold
Current Market Cap: $21.78M
Learn more about IINN stock on TipRanks’ Stock Analysis page.